VANCOUVER, British Columbia - illiNews -- Scientists today now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead our body and brain to decline as we age. Many believe that inflammation, stress, diet, exercise, and genetics greatly contribute to our aging process.
New studies are pointing to promising treatments that could slow, stop, or even reverse the signs of aging. This isn't just about turning back the clock in order to have a longer life span, its about extending our healthy years.
In one study, mice were given pills that mimicked the positive benefits of exercise. If it works in mice would it be effective in humans? And what does this portend for the future, if our lifespan increases and we all live decades longer?
The business of anti-aging and rejuvenation is gaining steam and should be on the radar of investors — the Bank of America has forecasted that the market will balloon from $110 billion today, to nearly to $610 billion by 2025.
Researchers have jumped on this trend too. In 2012, only 73 trials were conducted to reverse aging and that number doubled by the end of 2017 to 145. In 2018, this industry accounted for the most significant amount of investment, as market participants attracted an amount close to $800M (for comparison, back in 2014, it was only about $100M). The number of investment deals is also growing, with the highest number of the past six years recorded in 2017 (25 according to CB Insights, up from 13 a year earlier).
More on illi News
Companies like Juvenescence have raised over $65M to build an ecosystem and pipeline of assets targeting aging, age-related disease and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningfully improve human health and extends our lifespan.
Here are additional industry developments we're excited about:
Juvenescence's portfolio currently includes Insilico Medicine, a next-generation artificial intelligence company specializing in the application of deep learning to drug discovery and ageing research. Juvenescence AI, a joint venture with Insilico Medicine focused on the clinical development of AI-generated compounds.
LyGenesis, a company with technology to use a patient's own lymph nodes as bioreactors to grow functioning ectopic organs.
AgeX Therapeutics, a company applying intellectual property related to cell immortality and pluripotency.
Finding the latest developments
We encourage investors to follow the latest advancements in anti-ageing and rejuvenation by reading magazines such as Nature and The New Scientist. Both publications recently featured interesting articles that highlighted recent developments. We also recommend following websites like fiercebiotech, scientificamerican and tracking Initial Public Offerings to find other companies developing innovative anti-aging technologies.
More on illi News
Whether you are looking for an early-stage investment opportunity or would like to join an investment at a later stage, be sure to do your homework or team up with a group that works together to buy or build biotech opportunities.
Contact us today: https://theravestmanagement.com/contact
DISCLAIMER: All insights, suggestions, and advice provided herein are for educational purposes only. Nothing contained in this article or within this web site should be interpreted as a recommendation to buy or sell any securities, nor make an offer, solicitation or recommendation of another kind. All readers should always do further research before making a final investment decision.
The author is not a United States Securities Dealer nor Broker nor US Investment Adviser.
New studies are pointing to promising treatments that could slow, stop, or even reverse the signs of aging. This isn't just about turning back the clock in order to have a longer life span, its about extending our healthy years.
In one study, mice were given pills that mimicked the positive benefits of exercise. If it works in mice would it be effective in humans? And what does this portend for the future, if our lifespan increases and we all live decades longer?
The business of anti-aging and rejuvenation is gaining steam and should be on the radar of investors — the Bank of America has forecasted that the market will balloon from $110 billion today, to nearly to $610 billion by 2025.
Researchers have jumped on this trend too. In 2012, only 73 trials were conducted to reverse aging and that number doubled by the end of 2017 to 145. In 2018, this industry accounted for the most significant amount of investment, as market participants attracted an amount close to $800M (for comparison, back in 2014, it was only about $100M). The number of investment deals is also growing, with the highest number of the past six years recorded in 2017 (25 according to CB Insights, up from 13 a year earlier).
More on illi News
- The City of Chicago and iHeartMedia Chicago's 107.5 WGCI Partner for Memorial Day Stay at Home Weekend
- Capgemini UK Plc Breaches GDPR Regulations
- Practicing mindfulness without addressing self-destructive habits is like placing a band-aid on a festering wound
- Glass Mosaic Artist Allison Eden Studios Pivots Into Fashion With Face Mask Line
- MR.LEATHER64TEN 2020 Contest Winner Announcement
Companies like Juvenescence have raised over $65M to build an ecosystem and pipeline of assets targeting aging, age-related disease and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningfully improve human health and extends our lifespan.
Here are additional industry developments we're excited about:
Juvenescence's portfolio currently includes Insilico Medicine, a next-generation artificial intelligence company specializing in the application of deep learning to drug discovery and ageing research. Juvenescence AI, a joint venture with Insilico Medicine focused on the clinical development of AI-generated compounds.
LyGenesis, a company with technology to use a patient's own lymph nodes as bioreactors to grow functioning ectopic organs.
AgeX Therapeutics, a company applying intellectual property related to cell immortality and pluripotency.
Finding the latest developments
We encourage investors to follow the latest advancements in anti-ageing and rejuvenation by reading magazines such as Nature and The New Scientist. Both publications recently featured interesting articles that highlighted recent developments. We also recommend following websites like fiercebiotech, scientificamerican and tracking Initial Public Offerings to find other companies developing innovative anti-aging technologies.
More on illi News
- Learning How to Shift Your Thinking is the Best Way to Protect Your Mental Health During This Pandemic
- Restech is proud to announce the launch of PepsinCheck, a PEPTEST product branded for the U.S. consumer market
- Mark Andeer Joins Rawcubes as Head of Sales and Marketing
- For the first time ever, an endangered leatherback sea turtle is being tracked after nesting on the Gulf Coast of Florida
- Amazing New Kids' Show Born of COVID - Full of Laughter and Surprising Depth
Whether you are looking for an early-stage investment opportunity or would like to join an investment at a later stage, be sure to do your homework or team up with a group that works together to buy or build biotech opportunities.
Contact us today: https://theravestmanagement.com/contact
DISCLAIMER: All insights, suggestions, and advice provided herein are for educational purposes only. Nothing contained in this article or within this web site should be interpreted as a recommendation to buy or sell any securities, nor make an offer, solicitation or recommendation of another kind. All readers should always do further research before making a final investment decision.
The author is not a United States Securities Dealer nor Broker nor US Investment Adviser.
Source: Theravest Management
Filed Under: Business
0 Comments
Latest on illi News
- Naperville Police Investigate May 19 Vehicle Hijacking
- MBK Senior Living Acquires Kirkwood Orange Assisted Living & Memory Care
- Cura Surgical Launches Silver-Plated Reusable Face Mask
- Michael Brown joins the Qnext Board Advisory Team and Brings Significant Insight on Applying Cybersecurity & Zero Trust Remote Access to Public Sector
- Symplast Partners with ChangeWell Training Academy to Present Three-Course Webinar Series Focused on Mastering Video Post-COVID
- U.S. Army Selects DiSTI to Build C-RAM II Operator and Maintenance Trainer (OMT)
- CRH Healthcare hires Veteran Operator as COO
- Onlive Server Launched Japan VPS Hosting with Cloud Computing Control Panel
- Student Essay Contest, Hosted By Humanist Canada, Call for Submissions
- Innovation Days USA 2019 Post Event Highlights
- Coherent Logix Joins the Edge AI and Vision Alliance
- Cleaning And Disinfecting Touchscreens For Covid-19
- Bid4Assets to Host First-Ever Online Tax Sale for Nye County, Nevada Treasurer
- Grace Helps Kids and Parents Understand COVID-19
- AI.Reverie Wins AFWERX Phase 1 SBIR Award From U.S. Air Force to Enhance Intelligence-Gathering
- Karen S. Wells Appointed CEO of Bridge Communities
- NACCE seeks 10 Community Colleges for Continuation of Pilot Phase II with Intuit
- Family-Owned All Volleyball Announces First Two Recipients of Covid-19 Fundraiser Proceeds
- Amour Genesis Project Partners With Local Wellness Community Center To Host Covid-19 Testing Event
- Pandemic reduces car crashes but speeding related accidents surge